Regeneron begins phase III trials of REGN-COV2; here's how antibody cocktail can help COVID-19 patients
Myupchar • 5 years agoCurrently, the antibody cocktail, developed by researchers at the University of Maryland School of Medicine and Regeneron, is in the phase 2 treatment trials stage
Two experimental Ebola drugs are saving lives in Congo by blocking the virus
• 6 years agoClinics & medical units have been given access to both drugs & patients can opt to take it over existing treatment.